Tender detail
Antibodies intended to prevent RSV disease for the RSV season 2026–2027
Summary
The tender concerns antibodies intended to prevent RSV disease for the RSV season 2026–2027, with a possible option period for the RSV season 2027–2028. Two products with the lowest comparison price that meet the mandatory requirements will be selected, and their use will be distributed at roughly 60% and 40% of the estimated consumption. Bidders should note that the exact compliance and qualification requirements must be checked in the tender documents.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.